Biolife Solutions (BLFS) Gross Profit (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Gross Profit data on file, last reported at $17.5 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $17.5 million, up 18.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.3 million (up 19.31% YoY), and the FY2025 annual result was $62.1 million, up 24.0% from the prior year.
• Gross Profit advanced to $17.5 million in Q1 2026 per BLFS's latest filing, from -$7.5 million in the prior quarter.
• Over five years, Gross Profit peaked at $35.5 million in Q3 2022 and troughed at -$37.3 million in Q4 2022.
• A 5-year average of $13.8 million and a median of $18.7 million in 2023 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2025: Gross Profit surged 111.31% in 2022, then sank 258.88% in 2025.
• A 5-year view of Gross Profit shows it stood at -$37.3 million in 2022, then gained by 25.15% to -$27.9 million in 2023, then jumped by 92.57% to -$2.1 million in 2024, then slumped by 258.88% to -$7.5 million in 2025, then jumped by 334.72% to $17.5 million in 2026.
• Business Quant data shows BLFS's Gross Profit at $17.5 million in Q1 2026, -$7.5 million in Q4 2025, and $25.5 million in Q3 2025.